The potential of resting-state functional magnetic resonance imaging for studying the pathophysiology of primary focal dystonia

Cover Page


Cite item

Full Text

Abstract

Resting-state functional magnetic resonance imaging (R-fMRI) assesses the state of low-frequency fluctuations of the BOLD-signal showing spontaneous neuronal activity in different areas of the brain. Hence, R-fMRI allows one to visualize the synchronicity of generation of certain neurophysiological phenomena in different regions of the central nervous system, including the ones being remote from one another, by linking them into a functional network and assessing brain connectivity in normal state and in pathology. This technique has proved itself in the study of neurodegenerative diseases. In this review, we present the results of using R-fMRI for the most common forms of primary focal dystonia (blepharospasm and cervical dystonia) compared to the data of task-based fMRI and some other neuroimaging technologies such as positron emission tomography and voxel-based morphometry. It has been demonstrated in many studies that R-fMRI allows to assess disturbances in cerebral architecture and complex rearrangements in the neural network in patients with focal dystonia, including those after administration of botulinum toxin. This makes it possible to study more thoroughly the pathophysiological foundations of focal dystonia and the variety of mechanisms of botulinum toxin therapy in patients with these pathologies, including the central (indirect) mechanisms of action of botulinum toxin.

About the authors

Olga V. Semenova

Research Center of Neurology

Author for correspondence.
Email: semenovaov@me.com
Россия, Moscow

Sofiya L. Timerbaeva

Research Center of Neurology

Email: semenovaov@me.com
Россия, Moscow

Rodion N. Konovalov

Research Center of Neurology

Email: semenovaov@me.com
ORCID iD: 0000-0001-5539-245X

Cand. Sci. (Med.), senior researcher, Neuroradiology department

Россия, 125367 Moscow, Volokolamskoye shosse, 80

References

  1. Marsden C.D., Quinn N.P. The dystonias. BMJ: British Medical Journal. 1990;300(6718):139. PMID: 2105790.
  2. Defazio G. The epidemiology of primary dystonia: current evidence and perspectives. European journal of neurology. 2010; 17(s1): 9-14. PMID: 20590802. doi: 10.1111/j.1468-1331.2010.03053.x.
  3. Epidemiological Study of Dystonia in Europe Collaborative G. A prevalence study of primary dystonia in eight European countries. Journal of neurology. 2000; 247(10): 787-92. PMID: 11127535.
  4. Kuyper D.J., Parra V., Aerts S. et al. Nonmotor manifestations of dystonia: a systematic review. Movement Disorders. 2011; 26(7): 1206-17. PMID: 21484874. doi: 10.1002/mds.23709.
  5. Albanese A., Asmus F., Bhatia K.P. et al. EFNS guidelines on diagnosis and treatment of primary dystonias. European Journal of Neurology. 2011; 18(1): 5-18. PMID: 20482602. doi: 10.1111/j.1468-1331.2010.03042.x.
  6. Phukan J., Albanese A., Gasser T., Warner T. Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. The Lancet Neurology. 2011; 10(12): 1074-85. PMID: 22030388. doi: 10.1016/S1474-4422(11)70232-0.
  7. Camfield L., Ben‐Shlomo Y., Warner T.T. Impact of cervical dystonia on quality of life. Movement disorders. 2002; 17(4): 838-41. PMID: 12210891. doi: 10.1002/mds.10127
  8. Albanese A. The clinical expression of primary dystonia. Journal of neurology. 2003;250(10):1145-51. PMID: 14586593. doi: 10.1007/s00415-003-0236-8.
  9. Nicoletti A., Aoki L., Nahas T.R., Matayoshi S. Essential blepharospasm: literature review. Arquivos brasileiros de oftalmologia. 2010; 73(5): 469-73. PMID: 21225137.
  10. Timerbaeva S.L. [Role of model neuroimaging in the studies of focal distonia]. Annals of Clinical and Experimental Neurology. 2012; 6(2): 48-54 (in Russ.).
  11. Gordon N.S. Focal dystonia, with special reference to writer's cramp. International journal of clinical practice. 2005; 59(9): 1088-90. PMID: 16115186. doi: 10.1111/j.1742-1241.2005.00603.x.
  12. Rhoad R.C., Stern P.J. Writer's cramp—a focal dystonia: etiology, diagnosis, and treatment. The Journal of hand surgery. 1993; 18(3): 541-4. PMID: 8515033. doi: 10.1016/0363-5023(93)90109-G.
  13. Hallett M., Evinger C., Jankovic J., Stacy M. Update on blepharospasm Report from the BEBRF International Workshop. Neurology. 2008;71(16):1275-82. PMID: 18852443. doi: 10.1212/01.wnl.0000327601.46315.85.
  14. Krasnov М.Yu., Timerbaeva S.L., Illarioshkin S.N. [Genetics of hereditary forms of dystonia]. Annals of Clinical and Experimental Neurology. 2013; 7(2): 55-60 (in Russ.).
  15. Delmaire C., Vidailhet M., Elbaz A. et al. Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp. Neurology. 2007;69(4):376-80. PMID: 17646630. doi: 10.1212/01.wnl.0000266591.49624.1a.
  16. Draganski B., Thun-Hohenstein C., Bogdahn U. et al. “Motor circuit” gray matter changes in idiopathic cervical dystonia. Neurology. 2003; 61(9): 1228-31. PMID: 14610125.
  17. Egger K., Mueller J., Schocke M. et al. Voxel based morphometry reveals specific gray matter changes in primary dystonia. Movement Disorders. 2007; 22(11): 1538-42. PMID: 17588241. doi: 10.1002/mds.21619.
  18. Schmidt K.E., Linden D., Goebel R. et al. Striatal activation during blepharospasm revealed by fMRI. Neurology. 2003;60(11):1738-43. PMID: 12796523.
  19. Zoons E., Booij J., Nederveen A.J. et al. Structural, functional and molecular imaging of the brain in primary focal dystonia—a review. Neuroimage. PMID: 21349339. doi: 10.1016/j.neuroimage.2011.02.045 2011;56(3):1011-20.
  20. Timerbaeva S.L. Fokal'nye i segmentarnye formy pervichnoy distonii: klinicheskie, patofiziologicheskie i molekulyarno-geneticheskie aspekty: dis... dokt. med. nauk [Focal and segmental forms of primary dystonia: clinical, pathophysiological and molecular-genetic aspects. D.Sci (Med.) diss.]. Moscow. 2012: 232 p. (in Russ.).
  21. Suzuki Y., Mizoguchi S., Kiyosawa M. et al. Glucose hypermetabolism in the thalamus of patients with essential blepharospasm. Journal of neurology. 2007; 254(7): 890-6. PMID: 17325818. doi: 10.1007/s00415-006-0468-5.
  22. Kerrison J.B., Lancaster J.L., Zamarripa F.E. et al. Positron emission tomography scanning in essential blepharospasm. American journal of ophthalmology. 2003; 136(5): 846-52. PMID: 14597035.
  23. Singer C., Velickovic M. Cervical dystonia: etiology and pathophysiology. Neurologic clinics. 2008; 26: 9-22. PMID: 18603165.
  24. Velickovic M., Benabou R., Brin M.F. Cervical dystonia. Drugs. 2001; 61(13): 1921-43. PMID: 11708764.
  25. Eidelberg D., Moeller J.R., Ishikawa T. et al. The metabolic topography of idiopathic torsion dystonia. Brain. 1995; 118(6): 1473-84. PMID: 8595478.
  26. Garraux G., Bauer A., Hanakawa T. et al. Changes in brain anatomy in focal hand dystonia. Annals of neurology. 2004; 55(5): 736-9. PMID: 15122716. doi: 10.1002/ana.20113.
  27. Obermann M., Yaldizli O., De Greiff A. et al. Morphometric changes of sensorimotor structures in focal dystonia. Movement disorders. 2007; 22(8): 1117-23. PMID: 17443700. doi: 10.1002/mds.21495.
  28. Pantano P., Totaro P., Fabbrini G. et al. A transverse and longitudinal MR imaging voxel-based morphometry study in patients with primary cervical dystonia. American journal of neuroradiology. 2011; 32(1): 81-4. PMID: 20947646. doi: 10.3174/ajnr.A2242.
  29. Dresel C., Li Y., Wilzeck V. et al. Multiple changes of functional connectivity between sensorimotor areas in focal hand dystonia. Journal of Neurology, Neurosurgery & Psychiatry. 2014; 85(11): 1245-52. PMID: 24706945. doi: 10.1136/jnnp-2013-307127.
  30. Hu X-Y., Wang L., Liu H., Zhang S-Z. Functional magnetic resonance imaging study of writer's cramp. Chinese medical journal. 2006;119(15):1263-71. PMID: 16919185.
  31. Oga T., Honda M., Toma K. et al. Abnormal cortical mechanisms of voluntary muscle relaxation in patients with writer’s cramp: an fMRI study. Brain. 2002; 125(4): 895-903. PMID: 11912121.
  32. Baker R.S., Andersen A.H., Morecraft R.J., Smith C.D. A functional magnetic resonance imaging study in patients with benign essential blepharospasm. Journal of neuro-ophthalmology. 2003; 23(1): 11-5. PMID: 12616082.
  33. Timerbaeva S.L., Konovalov R.N., Illarioshkin S.N. [Focal dystonia: mapping of cerebral motor zones with functional MRI]. Nevrologicheskiy zhurnal. 2012; 17(3): 23-29 (in Russ.).
  34. Opavský R., Hluštík P., Otruba P., Kaňovský P. Sensorimotor network in cervical dystonia and the effect of botulinum toxin treatment: a functional MRI study. Journal of the neurological sciences. 2011;306(1):71-5. PMID: 21492880. doi: 10.1016/j.jns.2011.03.040.
  35. Løkkegaard A., Herz D.M., Haagensen B.N. et al. Altered sensorimotor activation patterns in idiopathic dystonia—an activation likelihood estimation meta‐analysis of functional brain imaging studies. Human brain mapping. 2016; 37(2): 547-57. PMID: 26549606. doi: 10.1002/hbm.23050.
  36. Lee M.H., Smyser C.D., Shimony J.S. Resting-state fMRI: a review of methods and clinical applications. American Journal of Neuroradiology. 2013; 34(10): 1866-72. PMID: 22936095. doi: 10.3174/ajnr.A3263.
  37. Seliverstova E.V., Seliverstov Yu.A., Konovalov R.N., Illarioshkin S.N. [Resting-state fMRI: new possibilities for studying physiology and pathology of the brain]. Annals of Clinical and Experimental Neurology. 2013; 7(4): 39-44 (in Russ.).
  38. Delnooz C.S., Helmich R.C., Toni I., van de Warrenburg B. Reduced parietal connectivity with a premotor writing area in writer's cramp. Movement Disorders. 2012; 27(11): 1425-31. PMID: 22886735. doi: 10.1002/mds.25029.
  39. Delnooz C.S., Pasman J.W., Beckmann C.F., van de Warrenburg B. Task-free functional MRI in cervical dystonia reveals multi-network changes that partially normalize with botulinum toxin. PloS one. 2013; 8(5): e62877. PMID: 23650536. doi: 10.1371/journal.pone.0062877.
  40. Delnooz C.S., Pasman J.W., Beckmann C.F., van de Warrenburg B. Altered striatal and pallidal connectivity in cervical dystonia. Brain Structure and Function. 2015; 220(1): 513-23. PMID: 24259114. doi: 10.1007/s00429-013-0671-y.
  41. Yang J., Luo C., Song W. et al. Altered regional spontaneous neuronal activity in blepharospasm: a resting state fMRI study. Journal of neurology. 2013; 260(11): 2754-60. PMID: 23900755. doi: 10.1007/s00415-013-7042-8.
  42. Zhou B., Wang J., Huang Y. et al. A resting state functional magnetic resonance imaging study of patients with benign essential blepharospasm. Journal of Neuro-Ophthalmology. 2013; 33(3): 235-40. PMID: 23636105. doi: 10.1097/WNO.0b013e31828f69e5.
  43. Hinkley L.B., Sekihara K., Owen J.P. et al. Complex-value coherence mapping reveals novel abnormal resting-state functional connectivity networks in task-specific focal hand dystonia. Frontiers in neurology. 2013; 4: 149. PMID: 24133480. doi: 10.3389/fneur.2013.00149.
  44. Mohammadi B., Kollewe K., Samii A. et al. Changes in resting‐state brain networks in writer's cramp. Human brain mapping. 2012; 33(4): 840-8. PMID: 21484954. doi: 10.1002/hbm.21250.
  45. Battistella G., Termsarasab P., Ramdhani R.A. et al. Isolated focal dystonia as a disorder of large-scale functional networks. Cerebral Cortex. 2017; 27(2): 1203-1215. PMID: 26679193. doi: 10.1093/cercor/bhv313.
  46. Battistella G., Fuertinger S., Fleysher L. et al. Cortical sensorimotor alterations classify clinical phenotype and putative genotype of spasmodic dysphonia. European journal of neurology. 2016; 23(10): 1517-27. PMID: 27346568. doi: 10.1111/ene.13067.
  47. Camargo C., Cattai L., Teive H. Pain relief in cervical dystonia with botulinum toxin treatment. Toxins. 2015; 7(6): 2321-35. PMID: 26110508. doi: 10.3390/toxins7062321.
  48. Colosimo C., Tiple D., Berardelli A. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review. Neurotoxicity research. 2012; 22(4): 265-73. PMID: 22359151. doi: 10.1007/s12640-012-9314-y.
  49. Horwath-Winter J., Bergloeff J., Floegel I. et al. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye. British journal of ophthalmology. 2003; 87(1): 54-6. PMID: 12488263.
  50. Mills R.R., Pagan F.L. Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A. Patient preference and adherence. 2015;9:725. PMID: 26082621. doi: 10.2147/PPA.S75459.
  51. Ramirez-Castaneda J., Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins. 2013; 5(2): 249-66. PMID: 23381141. doi: 10.3390/toxins5020249.
  52. Timerbaeva S.L., Ivanova-Smolenskaya I.A., Markova E.D. et al. [Botulinum toxin-A is a highly effective treatment for focal dystonias]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2000; (5): 32-5 (in Russ.).
  53. Nevrly M., Hlustik P., Otruba P. et al. Changes in sensorimotor network activations after botulinum toxin type a injections in patients with cervical dystonia. A functional MRI study. Parkinsonism & Related Disorders. 2012; 18: 71. DOI: http://dx.doi.org/10.1016/S1353-8020(11)70356-X.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Semenova O.V., Timerbaeva S.L., Konovalov R.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies